Rockwell proceeding with Phase III trial of dialysate-added iron. PDF Print
Globe Newswire: Rockwell Medical ... announced today that it has commenced enrollment in its pivotal Phase III CRUISE-1 clinical study, designed to treat iron deficiency anemia in hemodialysis dependent-chronic kidney disease patients receiving erythropoietin.

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.